Sitemap - 2024 - BowTiedBiotech
Epoch 52: 10 Biotech Buyout Predictions for 2025
Epoch 52: Sweat Equity - Your Weekly Biotech News Fix
Epoch 52: Top Articles of 2024
The Odds of Biotechs Getting Acquired
25 Biotech Predictions for 2025
Epoch 51: 25 Biotech Predictions for 2025
Epoch 51: Sweat Equity - Your Weekly Biotech News Fix
AI in Drug Target Discovery: A Peak into Tomorrow
EPOCH 51: BIOTECH MARKET RESEARCH $IONS
Epoch 50: Top 10 Biotech Themes from 2024
Epoch 50: Sweat Equity - Your Weekly Biotech News Fix
Epoch 50: Venture Capital is Patient Capital
2024: The Year of Biotech Insane Megarounds
EPOCH 50: BIOTECH MARKET RESEARCH $NMRA
Epoch 49: Cheat Sheet to Biotech Impacts of Trump’s Healthcare Appointees
Epoch 49: Sweat Equity - Your Weekly Biotech News Fix
Epoch 49: Biotech Dealmaking - Follow the Smart Money
Predicting the Next Big Biotech M&A: Trends, Timelines, and Top Candidates
EPOCH 49: BIOTECH MARKET RESEARCH $JANX
Epoch 48: Why Biotechs Are Buying Bitcoin
🎙️ Exciting News: The BowtiedBiotech Podcast is Now on Spotify! 🎉
Epoch 48: Sweat Equity - Your Weekly Biotech News Fix
Epoch 48: Regulatory & Geopolitical Forces Shaping Biotech
The Race to Tackle Neuroinflammation in Modern Neuroscience
EPOCH 48: BIOTECH MARKET RESEARCH $ALEC
Epoch 47: Vivek & Balaji Talk Biotech
Epoch 47: Sweat Equity - Your Weekly Biotech News Fix
Epoch 47: Is the Biotech Valuation Reset Complete?
Leverage and Cash Recycling in Venture Capital: Amplifying Gains
EPOCH 47: BIOTECH MARKET RESEARCH $PYXS
Epoch 46: The Biotech Investor’s Guide to Pre-Catalyst Timing
Epoch 46: Sweat Equity - Your Weekly Biotech News Fix
Epoch 46: Capital in Motion - Which Biotech Investors Are Placing Bets in 2024
Novartis' "Glue Degrader" Drug Candidate for Sickle Cell Disease Shows Promise
EPOCH 46: BIOTECH MARKET RESEARCH $BHVN
Epoch 45: Family Offices & Biotech
Epoch 45: Sweat Equity - Your Weekly Biotech News Fix
Epoch 45: Biotech Valuations Waking Up?
Venture Capital Strategy: Good vs. Great
EPOCH 45: BIOTECH MARKET RESEARCH $CABA
Epoch 44: US vs EU Venture Capital
Epoch 44: Sweat Equity - Your Weekly Biotech News Fix
Epoch 44: Biotech Capital Allocation Trends
Cash Runway Crisis and Reverse Mergers: The Growing Landscape of Financial Zombie Biotechs
EPOCH 44: BIOTECH MARKET RESEARCH $LXRX
Epoch 43: Reigniting European Leadership in Life Sciences
Epoch 43: Sweat Equity - Your Weekly Biotech News Fix
Epoch 43: Biotech Survey Says!
Cash Runway Crisis and Reverse Mergers
EPOCH 43: BIOTECH MARKET RESEARCH $SYRS
Epoch 42: Viral Reactivation - An Untapped Gold Mine
Epoch 42: Sweat Equity - Your Weekly Biotech News Fix
Epoch 42: Biotech Capital Markets Remain Muted
How Do Venture Capitalists Make Decisions
EPOCH 42: BIOTECH MARKET RESEARCH $AMLX
Epoch 41: Building Billion-Dollar Drugs
Epoch 41: Sweat Equity - Your Weekly Biotech News Fix
Epoch 41: Understanding Private Biotech VC Returns
The Venture Mirage: Why Surviving Isn’t Thriving in Startup Land
EPOCH 41: BIOTECH MARKET RESEARCH $IMTX
Epoch 40: Trillion Dollar Biopharma - Tech vs Biotech
Sweat Equity - Your Weekly Biotech News Fix
Epoch 40: Sweat Equity - Your Weekly Biotech News Fix
Epoch 40: Biotech VC Performance as a Proxy for Market Health
Epoch 40: Rewiring the Rules of Biology
EPOCH 40: BIOTECH MARKET RESEARCH $VSTM
The BowtiedBiotech Podcast: Epoch 39 - Building Commercial Biotech Capability
Epoch 39: Building Commercial Biotech Capability
Epoch 39: Sweat Equity - Your Weekly Biotech News Fix
Epoch 39: Unmasking The Top Biotech Exit Enablers
EPOCH 39: BIOTECH MARKET RESEARCH $RPTX
Epoch 38: SURVEY OF THE CRISPR CLINICAL LANDSCAPE
Epoch 38: Sweat Equity - Your Weekly Biotech News Fix
Epoch 38: BIOTECH HEALTH - IS UP REALLY UP?
Epoch 38: CRISPR Corner: Monthly Gene Editing Updates
EPOCH 38: BIOTECH MARKET RESEARCH $ZVRA
Epoch 37: Sweat Equity - Your Weekly Biotech News Fix
Preview of the ESMO 2024 Conference
Epoch 37: Biotech Venture Capital Trends
EPOCH 37: BIOTECH MARKET RESEARCH $CCCC
Epoch 36: Tough Times in the Biopharma Job Market
Epoch 36: Sweat Equity - Your Weekly Biotech News Fix
Epoch 36: VC Fund Performance Metrics
EPOCH 36: BIOTECH MARKET RESEARCH $BDTX
Epoch 35: Work From Home in the Post-COVID World
Epoch 35: Sweat Equity - Your Weekly Biotech News Fix
Epoch 35: A DATA-DRIVEN GUIDE TO BIOTECH INVESTMENT STRATEGY
EPOCH 35: BIOTECH MARKET RESEARCH $VRDN
Epoch 34: The Emerging Titans - The Journey to Big Pharma Status
Epoch 34: Sweat Equity - Your Weekly Biotech News Fix
Epoch 34: Chasing Blockbusters - High-Stakes Approvals Define 1H 2024
EPOCH 34: BIOTECH MARKET RESEARCH $IMCR
Epoch 33: I&I Therapeutics Beyond CAR-T
Epoch 33: Sweat Equity - Your Weekly Biotech News Fix
Epoch 33: How the Biggest Investors in Biotech Have Been Behaving
EPOCH 33: BIOTECH MARKET RESEARCH $JSPR
Epoch 32: Obesity Therapeutics 2.0 - Next Wave Mechanisms of Action
Epoch 32: Sweat Equity - Your Weekly Biotech News Fix
Epoch 32: Key Biotech Market Takeaways from 1H24
EPOCH 32: BIOTECH MARKET RESEARCH $RZLT
Epoch 31:The History of Antibodies in Oncology
Epoch 31: Sweat Equity - Your Weekly Biotech News Fix
Epoch 31: More M&A in the Works?
EPOCH 31: BIOTECH MARKET RESEARCH $SPRB
Epoch 30: Metabolic RNA Silencing
Epoch 30: Sweat Equity - Your Weekly Biotech News Fix
Epoch 30: Biotech Private Markets Gaining Momentum
EPOCH 30: BIOTECH MARKET RESEARCH $ALXO
Epoch 29: Unlocking Biopharma Gains by Mimicking Top Hedge Funds
Epoch 29: Sweat Equity - Your Weekly Biotech News Fix
Epoch 29: The Summer of Biotech
Epoch 28: I&I Drug Development Tracker
EPOCH 29: BIOTECH MARKET RESEARCH $RVMD
Epoch 28: Raising Money in Biotech? Plan for Longer than Expected
EPOCH 28: BIOTECH MARKET RESEARCH $GRTS
Epoch 27: Trump vs Biden & How to Sanely Discuss
Epoch 27: Sweat Equity - Your Weekly Biotech News Fix
Epoch 27: Survival of the Fittest - Biotech Industry Faces Shutdowns & Consolidation
Epoch 27: CRISPR Corner: Monthly Gene Editing Updates
EPOCH 27: BIOTECH MARKET RESEARCH $PFE
Epoch 26: Innovative Trial Designs for Auto-Immune & Inflammatory Diseases
Epoch 26: Do Failed Clinical Trials Matter?
EPOCH 26: BIOTECH MARKET RESEARCH $GTHX
Epoch 25: Biotech Salaries Under Pressure
Epoch 25: Sweat Equity - Your Weekly Biotech News Fix
Epoch 25: Biotech 2024 - Beg vs. Bridge
EPOCH 25: BIOTECH MARKET RESEARCH $ALNY
Epoch 24: Embracing the Yin and Yang of M&A and Shutdowns
Epoch 24: Sweat Equity - Your Weekly Biotech News Fix
Epoch 24: Nothing is Easy in Biotech
EPOCH 24: BIOTECH MARKET RESEARCH $SRPT
Epoch 23: BCI Brain Computer Interface
Epoch 23: Sweat Equity - Your Weekly Biotech News Fix
Epoch 23: Private Biotech Capital Allocation Trends
EPOCH 23: BIOTECH MARKET RESEARCH $URGN
Epoch 22: Is it Hard to Be a Biotech VC?
Epoch 22: Sweat Equity - Your Weekly Biotech News Fix
Epoch 22: A Proxy for Market Health - the Initial Public Offering (IPO)
EPOCH 22: BIOTECH MARKET RESEARCH $AVTE
Epoch 21: Modernizing Clinical Development
Epoch 21: SPECIAL EDITION - ASCO 2024
Epoch 21: Sweat Equity - Your Weekly Biotech News Fix
Epoch 21: Private Valuations & Pharma Shopping Lists
Epoch 21: CRISPR Corner: Monthly Gene Editing Updates
Epoch 20: Measuring & Maximizing Clinical Productivity
Epoch 20: Sweat Equity - Your Weekly Biotech News Fix
Epoch 20: Biotechs Most Active Investors
EPOCH 21: BIOTECH MARKET RESEARCH $OLMA
EPOCH 20: BIOTECH MARKET RESEARCH $SANA
Epoch 19: The AutoImmune Renaissance
Epoch 19: Sweat Equity - Your Weekly Biotech News Fix
Epoch 19: Let’s Make a Biotech Deal
EPOCH 19: BIOTECH MARKET RESEARCH $CABA
Epoch 18: Fees for Returns, or Returns for Fees?
Epoch 18: Sweat Equity - Your Weekly Biotech News Fix
Epoch 18: The Capital Conveyor Belt - How Investment Flows Shape Biotech
EPOCH 18: BIOTECH MARKET RESEARCH $BHVN
Epoch 17: Fibrosis- From Basics to Breakthroughs
Epoch 17: Sweat Equity - Your Weekly Biotech News Fix
EPOCH 17: BIOTECH MARKET RESEARCH $INSM
Epoch 16: Engineering Your Body's Own Defense: How Cell Therapy Fights Autoimmunity
Epoch 16: Sweat Equity - Your Weekly Biotech News Fix
Epoch 16: Gaining an Edge in Post-Pandemic Biotech
EPOCH 16: BIOTECH MARKET RESEARCH $DAWN
Epoch 15: CRISPR Corner: Monthly Gene Editing Updates
Epoch 15: Sweat Equity - Your Weekly Biotech News Fix
Epoch 15: Macro Headwinds Challenging the XBI Run
EPOCH 15: BIOTECH MARKET RESEARCH $XFOR
Epoch 14: Peak Sales Rules Everything Around Me
Epoch 14: Sweat Equity - Your Weekly Biotech News Fix
Epoch 14: Decoding Hidden Indicators of Biotech Health
EPOCH 14: BIOTECH MARKET RESEARCH $OCUL
Epoch 13: The Approval Equation - Unpacking This Year's Drug Approval Trends
Epoch 13: Sweat Equity - Your Weekly Biotech News Fix
Epoch 13: Big Biotech Breakout in the Works?
EPOCH 13: BIOTECH MARKET RESEARCH $SAGE
Epoch 12: Clinical Development Operations Tends
Epoch 12: Sweat Equity - Your Weekly Biotech News Fix
EPOCH 12: BIOTECH MARKET RESEARCH $ALT
Epoch 11: Investing in Innovation: A Look at Biopharma R&D Spending Trends
Epoch 11: Sweat Equity - Your Weekly Biotech News Fix
Epoch 11: Grants to Greenbacks - Biotech's Funding Journey
EPOCH 11: BIOTECH MARKET RESEARCH $MDGL
Epoch 10: Beyond the Bucks - How Specialist Investors Fuel Biotech Success
Epoch 10: Sweat Equity - Your Weekly Biotech News Fix
Epoch 10: Hacking Biotech: Capital Allocation, Recycling, and Liquidation Preferences
Epoch 10: CRISPR Corner: Monthly Gene Editing Updates
EPOCH 10: BIOTECH MARKET RESEARCH $RNA
Epoch 9: Roche Goes Digital: A Day in the Life of the Future
Epoch 7: Sweat Equity - Your Weekly Biotech News Fix
EPOCH 9: ***BONUS ALERT*** BIOTECH MARKET RESEARCH $AKRO
Epoch 9: What Downturn? Europe's VC Market Defies Gravity
EPOCH 9: BIOTECH MARKET RESEARCH $VKTX
Epoch 8: Biotech Hiring Best Practices
Epoch 8: Sweat Equity - Your Weekly Biotech News Fix
Epoch 8: Something is Cooking in Biotech
EPOCH 8: BIOTECH MARKET RESEARCH $IOVA
Epoch 7: Decoding Signals That Move Big Pharma Stocks
Epoch 7: Sweat Equity - Your Weekly Biotech News Fix
Epoch 7: XBI Stuck in Neutral as Market Activity Gears Up
EPOCH 7: BIOTECH MARKET RESEARCH $MACK
Epoch 6: Is Cost-Effectiveness Killing Innovation?
Epoch 6: Sweat Equity - Your Weekly Biotech News Fix
Epoch 6: Demystifying Biotech Metrics with Data & Dollars
Epoch 6: CRISPR Corner: Monthly Gene Editing Updates
EPOCH 6: BIOTECH MARKET RESEARCH $DNLI
Epoch 5: CV & Obesity Overview - GLP-1 & Beyond
Epoch 5: Sweat Equity - Your Weekly Biotech News Fix
Epoch 5: GLOBAL BIOTECH OUTLOOK THROUGH 2028
EPOCH 5: BIOTECH MARKET RESEARCH $FDMT
Epoch 4: Biotech Contrarian Investing
Epoch 4: Sweat Equity - Your Weekly Biotech News Fix
Epoch 4: Using Slow Times to Prepare for Fast Times
EPOCH 4: BIOTECH MARKET RESEARCH $RARE
Epoch 3: Founder Psychology Differs From the Population
Epoch 3: Sweat Equity - Your Weekly Biotech News Fix
Epoch 3: Slow Week in Biotech - Post-JPM Hangover
Epoch 2: Sweat Equity - Your Weekly Biotech News Fix
Epoch 2: Biotech Poised for 2024 Recovery
Epoch 1: JPM 2024 Event & Survival Guide
Epoch 1: Sweat Equity: Your Weekly Biotech News Fix